<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-157455</identifier>
<setSpec>1888-9891</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Differential blood-based biomarkers of psychopathological dimensions of schizophrenia</dc:title>
<dc:description xml:lang="en">Symptomatology of schizophrenia is heterogeneous, there is not any pathognomonic symptom. Moreover, the diagnosis is difficult, since it is based on subjective information, instead of markers. The purpose of this study is to provide a review of the current status of blood-based biomarkers of psychopathological dimensions of schizophrenia. Inflammatory, hormonal or metabolic dysfunctions have been identified in patients with schizophrenia and it has attempted to establish biomarkers responsible for these dysfunctions. The identification of these biomarkers could contribute to the diagnosis and treatment of schizophrenia (AU)</dc:description>
<dc:creator>Bobes, Julio</dc:creator>
<dc:creator>Garcia-Alvarez, Leticia</dc:creator>
<dc:creator>Gonzalez-Blanco, Leticia</dc:creator>
<dc:creator>Fuente-Tomas, Lorena de la</dc:creator>
<dc:creator>Saiz Martinez, Pilar Alejandra</dc:creator>
<dc:creator>Menendez-Miranda, Isabel</dc:creator>
<dc:creator>Iglesias, Celso</dc:creator>
<dc:creator>Garcia-Portilla, Maria Paz</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La sintomatología de la esquizofrenia es heterogénea, no existiendo ningún síntoma patognomónico de la misma. Además, su diagnóstico presenta dificultades, ya que se basa en información subjetiva en lugar de en marcadores. El propósito de este estudio es ofrecer una revisión del estado actual de los biomarcadores sanguíneos de las dimensiones psicopatológicas de la esquizofrenia. En pacientes con esquizofrenia se han observado disfunciones inflamatorias, hormonales o metabólicas y se ha intentado establecer los biomarcadores responsables de esas disfunciones. La identificación de estos podría contribuir al diagnóstico y tratamiento de la esquizofrenia (AU)</dc:description>
<dc:source>Rev. psiquiatr. salud ment. (Barc., Ed. impr.);9(4): 219-227, oct.-dic. 2016. tab</dc:source>
<dc:identifier>ibc-157455</dc:identifier>
<dc:title xml:lang="es">Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d23568^s22062</dc:subject>
<dc:subject>^d28903^s22062</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12940^s22062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12940^s22032</dc:subject>
<dc:subject>^d28903^s22002</dc:subject>
<dc:subject>^d12940^s22016</dc:subject>
<dc:subject>^d12035^s22048</dc:subject>
<dc:subject>^d3102^s22031</dc:subject>
<dc:subject>^d12035^s22066</dc:subject>
<dc:subject>^d12035^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201612</dc:date>
</metadata>
</record>
</ibecs-document>
